Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
129Xe MRI for Lung Function Assessment
NCT01280994Phase 2Recruiting
- Start
- Jan 2011
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in interstitial lung disease (ILD), pulmonary disease. Started Jan 2011; status: recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
interstitial lung disease (ILD)pulmonary disease
Beyond the preview
Go deeper on NCT01280994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280994.